Project Grant R21NS139210
Award Date
7/5/24
Completion Date
6/30/26
Dollars Obligated
$438K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund research at the University of California, San Diego (UCSD) to explore the role of liquid-liquid phase separation (LLPS) in regulating neuronal heterochromatin. The $941,337 award, effective August 1, 2024 through May 31, 2029, will support experiments using novel in vivo genetic...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $233,250 to the University of North Carolina at Chapel Hill to develop an improved luciferase-based biosensor capable of quantifying endogenous UBE3A ubiquitin ligase activity. The goal is to create a non-invasive tool to measure UBE3A levels in cells and mouse models,...
Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to elucidate the subcellular dynamics of ubiquitination, a key biological process regulating synaptic function and neuronal health, using advanced single-molecule imaging techniques. The research aims to uncover new mechanisms by...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $236,250 to the University of California, Los Angeles (UCLA) to conduct research on how alternative splicing of the DPF2 chromatin remodeling protein regulates epigenetic programs during brain development. The project aims to determine how the brain-specific DPF2-L...
This Project Grant award of $427,625 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will be used by the University of Wisconsin - Madison to systematically identify differentially ubiquitinated proteins, potentially UBE3A substrates, in UBE3A model mice across different cell types (excitatory and inhibitory neurons) and developmental stages. The researchers will...
This federal Project Grant award of $985,026 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, aims to investigate the roles and mechanisms of epitranscriptomic regulation in the development and function of the mammalian nervous system, as well as the pathological consequences of disrupting these processes. The research program will utilize mouse models and human induced...
This $195,570 federal Project Grant award was made by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research by The Regents of the University of California, San Francisco (UCSF) to investigate the role of the molecular co-chaperone DNAJC7 in preventing the aggregation of misfolded proteins associated with neurodegenerative diseases such as...
This federal Project Grant award for $858,471.00, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research focused on understanding the role of N-terminal acetylation in alpha-synuclein stability, function, and therapeutic targeting for Parkinson's disease and related neurodegenerative disorders. The key objectives are to: 1) Identify the molecular...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $168,321.00 to the Regents of the University of Michigan to investigate mechanisms of NPC1 protein homeostasis in human neurons. The goal is to determine the effectors that regulate the folding, trafficking, and degradation of the NPC1 protein in neurons, a critical cell type...